Under the section Scientific Content in the ODD Annual report, there is a question that states "Other marketing authorisations?". Could you please clarify what exactly is being asked with this question? Does this only concern EMA or could it also be FDA approvals? If it is for markets outside the EU, does it include other indications as well? Does this mean any marketing authorisation within the indication area?
